Cargando…

Thyroid function after diagnostic (123)I-metaiodobenzylguanidine in children with neuroblastic tumors

BACKGROUND: Metaiodobenzylguanidine (MIBG) labeled with radioisotopes can be used for diagnostics (123)I(−)) and treatment ((131)I(−)) in patients with neuroblastic tumors. Thyroid dysfunction has been reported in 52% of neuroblastoma (NBL) survivors after (131)I-MIBG, despite thyroid protection. Di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clement, Sarah C., Tytgat, Godelieve A. M., van Trotsenburg, A. S. Paul, Kremer, Leontien C. M., van Santen, Hanneke M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132835/ https://www.ncbi.nlm.nih.gov/pubmed/35499668 http://dx.doi.org/10.1007/s12149-022-01743-7

Ejemplares similares

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis
por: Noordzij, Walter, et al.
Publicado: (2012)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)

The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013)

Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022)

Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington’s disease
por: Assante, Roberta, et al.
Publicado: (2020)

I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients
por: Zhou, Weihua, et al.
Publicado: (2013)

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013)

Complete remission of metastatic pheochromocytoma in (123)I-metaiodobenzylguanidine scintigraphy after a single session of (131)I-metaiodobenzylguanidine therapy: a case report
por: Sugino, Teruaki, et al.
Publicado: (2017)

Diagnostic Accuracy of Apparent Diffusion Coefficient and (123)I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson’s Disease
por: Umemura, Atsushi, et al.
Publicado: (2013)

Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Cardiac (123)I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Parkin Gene Mutation
por: Kim, Young-Do, et al.
Publicado: (2010)

(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
por: Chung, Eun Joo, et al.
Publicado: (2015)

False Positive Radioiodinated Metaiodobenzylguanidine ((123)I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor
por: Jung, Hee Soo, et al.
Publicado: (2015)

Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio
por: Okuda, Koichi, et al.
Publicado: (2023)

Two Cases of Decreased (123)I-Metaiodobenzylguanidine Lung Uptake in Metaiodobenzylguanidine Scintigraphy While Taking Selective Serotonin Reuptake Inhibitor/Serotonin Noradrenaline Reuptake Inhibitor
por: Adaniya, Shinobu, et al.
Publicado: (2021)

Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations
por: Nakajima, Kenichi, et al.
Publicado: (2014)

Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2018)

HIV Dementia with a Decreased Cardiac (123)I-metaiodobenzylguanidine Uptake Masquerading as Dementia with Lewy Bodies
por: Kurihara, Masanori, et al.
Publicado: (2018)

Changes in cardiac sympathetic nerve activity on (123)I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy
por: Fukuda, Keisuke, et al.
Publicado: (2021)

Convolutional neural network-based automatic heart segmentation and quantitation in (123)I-metaiodobenzylguanidine SPECT imaging
por: Saito, Shintaro, et al.
Publicado: (2021)

Variations in (123)I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation
por: Verberne, Hein J., et al.
Publicado: (2007)

The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine ((123)I-MIBG) uptake: A case report
por: Higo, Kenjuro, et al.
Publicado: (2020)

A Case of (123)I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene
por: Kubo, Haremaru, et al.
Publicado: (2022)

Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure
por: Ishibashi, Yohei, et al.
Publicado: (2023)

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
por: Bax, Jeroen J., et al.
Publicado: (2008)

Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added (123)I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity
por: Verberne, Hein J., et al.
Publicado: (2008)

Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of (123)I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability
por: Scholte, Arthur J. H. A., et al.
Publicado: (2010)

Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An (123)I-metaiodobenzylguanidine SPECT/CT study
por: Todica, Andrei, et al.
Publicado: (2018)

Is (123)I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database
por: Nakajima, Kenichi, et al.
Publicado: (2018)

Prognostic value of cardiac (123)I‐metaiodobenzylguanidine imaging for predicting cardiac events after transcatheter aortic valve replacement
por: Kadoya, Yoshito, et al.
Publicado: (2021)

(123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
por: Kitamura, Yoshiyuki, et al.
Publicado: (2021)

Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac (123)I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT
por: Saito, Shintaro, et al.
Publicado: (2023)

The Potential Role of Iodine-123 Metaiodobenzylguanidine Imaging for Identifying Sustained Ventricular Tachycardia in Patients with Cardiomyopathy
por: Klein, Thomas, et al.
Publicado: (2013)

Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation
por: Teresińska, Anna
Publicado: (2018)

A prediction model for 5-year cardiac mortality in patients with chronic heart failure using (123)I-metaiodobenzylguanidine imaging
por: Nakajima, Kenichi, et al.
Publicado: (2014)

Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
por: Lamotte, Guillaume, et al.
Publicado: (2015)

Machine learning-based risk model using (123)I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure
por: Nakajima, Kenichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgou750q987rs8b2jhiauq4mof